Search

Your search keyword '"CHEMICAL inhibitors"' showing total 22 results
Start Over Descriptor "CHEMICAL inhibitors" Publication Type Reviews
22 results on '"CHEMICAL inhibitors"'

1. Sparsentan.

Subjects
*ENDOTHELINS, *CELL receptors, *PROTEINURIA, *DRUG interactions, *ANGIOTENSIN receptors, *PHARMACY information services, *DOSAGE forms of drugs, *CHEMICAL inhibitors
Abstract

The article reviews he Sparsentan endothelin and angiotensin II receptor antagonist drug for treating primary immunoglobulin A nephropathy (IgAN) from Travere Therapeutics.

Published
2023
Full Text
View/download PDF

2. Rolapitant.

Author

Cada, Dennis J., Bindler, Ross, and Baker, Danial E.

Subjects
*ANTIEMETICS, *CANCER chemotherapy, *DRUGS, *NEUROTRANSMITTERS, *CONTINUING education units, *CHEMICAL inhibitors
Abstract

The article evaluates the clinical efficiency of Rolapitant, a drug approved by the U.S. Food and Drug Administration for the prevention of delayed nausea associated with the use of emetogenic chemotherapy.

Published
2016
Full Text
View/download PDF

3. CE. New drugs 2015 part 1.

Author

Hussar, Daniel A.

Subjects
*ANTI-inflammatory agents, *ANTICONVULSANTS, *DRUG therapy for convulsions, *ESTROGEN replacement therapy, *HYPOGLYCEMIC agents, *BRONCHODILATOR agents, *ESTERASES, *IMPOTENCE, *OBSTRUCTIVE lung diseases, *MENOPAUSE, *NURSING practice, *PSORIATIC arthritis, *SPASMS, *DRUG approval, *CHEMICAL inhibitors, *THERAPEUTICS
Abstract

The article offers information on several drugs including the Apremilast, an anti-inflammatory drug, from Celgene Corp., the Avanafil for penile dysfunction from Vivus Inc. and the Perampanel antiepileptic drug from Eisai Inc.

Published
2015
Full Text
View/download PDF

4. Hypoxia, HIF1 and glucose metabolism in the solid tumour.

Author

Denko, Nicholas C.

Subjects
*HYPOXEMIA, *TUMORS, *CANCER cells, *CELL metabolism, *GLUCOSE, *GENES, *TISSUES, *GLYCOLYSIS, *MITOCHONDRIAL physiology, *PROTEIN metabolism, *GLUCOSE metabolism, *REACTIVE oxygen species, *BIOLOGICAL models, *CELL division, *CELL physiology, *PROTEINS, *CHEMICAL inhibitors
Abstract

It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

5. Gefitinib--a novel targeted approach to treating cancer.

Author

Herbst, Roy S., Fukuoka, Masahiro, Baselga, José, and Baselga, José

Subjects
*EPIDERMAL growth factor, *ANTINEOPLASTIC agents, *DRUG receptors, *CHEMICAL inhibitors, *SMALL cell lung cancer, *CANCER treatment, *GROWTH factors, *HETEROCYCLIC compounds, *LUNG cancer, *LUNG tumors, *PROTEIN-tyrosine kinases
Abstract

Twenty years after the epidermal growth factor receptor (EGFR) was identified as a potential anticancer target, the EGFR inhibitor gefitinib (Iressa; AstraZeneca) has been approved for the treatment of patients with advanced non-small-cell lung cancer in many countries. Studies have indicated its potential for treating patients with other types of solid tumours. Investigation of gefitinib has not only increased our knowledge about the biology of EGFR signalling, but is contributing to our evolving understanding of which tumours are EGFR dependent. [ABSTRACT FROM AUTHOR]

Published
2004
Full Text
View/download PDF

6. NEW PRODUCTS.

Subjects
*DRUGS, *DRUG tablets, *CHEMICAL inhibitors
Published
2018

7. Corrosion Behavior of Alloy A3003 After Brazing in HCl, CH3COOH, and Mixed Solutions.

Author

Shohei Iwao, Michihide Yoshino, Masakazu Edo, and Shu Kuroda

Subjects
CORROSION & anti-corrosives, CHEMICAL inhibitors, ALLOYS, HYDROGEN, CHLORINE compounds
Abstract

Dip and dry corrosion tests were carried out on Alloy A3003 (UNS A93003] using hydrochloric acid (HCl), acetic acid (CH3COOH), and a mixed solution. After 50 corrosion test cycles with the HCl solution, pitting corrosion occurred in some parts at higher concentrations, but corrosion weight loss was very low. In the case of the CH3COOH solution, general corrosion occurred, thickness decreased, and weight loss significantly increased as the concentration grew. In the case of the mixed solution, both general corrosion and pitting corrosion occurred, and corrosion mass loss increased as the HCl concentration grew. Also, in concentrations of more than 50 ppm of HCl, the number of pits significantly increased. Electrochemical polarization measurements were done to understand the corrosion forms for each acid. In the electrochemical polarization, the pitting potential became less noble with increasing concentration of HCl. No distinct effect of CH3COOH on the pitting potential w a s confirmed, but corrosion current density increased with increasing concentration of CH3COOH. For the mixed solution, both of these effects were confirmed. These electrochemical polarization results correspond well with the dip and dry corrosion test results. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

8. New drugs and dosage forms.

Subjects
*AMPHETAMINES, *ANTI-infective agents, *MONOCLONAL antibodies, *PHOSPHOTRANSFERASES, *VASODILATORS, *BEVACIZUMAB, *FLUTICASONE, *CHEMICAL inhibitors
Abstract

The article offers information on various drugs and dosage forms in the U.S. including Adzenys ER amphetamine extended-release oral suspension from Neos Therapeutics, Bayer's Aliqopa copanlisib for injection, and Amgen's Mvasi bevacizumab-awwb solution.

Published
2017

9. The MP Blog.

Subjects
BLOGS, WEB 2.0, CORROSION & anti-corrosives, CHEMICAL inhibitors, DEW point
Abstract

Blog entries from readers on corrosion issues are presented including dew point corrosion, materials for polyvinyl chloride (PVC) and iron content in zinc anodes.

Published
2009

10. Afatinib Tablets (Gilotrif™).

Author

Elliott, William T. and Chan, James

Subjects
*LUNG cancer & genetics, *EPIDERMAL growth factor, *LUNG cancer, *GENETIC mutation, *ORAL drug administration, *CHEMICAL inhibitors, *PROTEIN-tyrosine kinase inhibitors, *THERAPEUTICS
Abstract

The article evaluates the Afatinib Tablets (Gilotrif) for treatment of non-small cell lung cancer (NSCLC) by Boehringer Ingelheim Pharmaceuticals.

Published
2013

11. HYPERTENSION TREATMENTS: ORAL CCBs.

Subjects
*CHEMICAL inhibitors, *DRUG tablets, *DRUG therapy
Abstract

The article evaluates several oral calcium channel blocker drugs including the dihydropyridine Norvasc tablet from pharmaceutical company Pfizer Inc., the diphenylalkamine Calan SR from drug manufacturer Pfizer Inc., and benzothiazepine Tizac from Biovail Laboratories International Srl.

Published
2013

12. New Products.

Subjects
*BIOLOGICAL laboratory equipment, *HOT water heating, *MICROPLATES, *MICRORNA, *CHEMICAL inhibitors
Abstract

The article offers information on life science laboratory products, including heated circulating water baths by PolyScience, the SpectraMax i3 Multi-Mode Detection Platform microplate reader from Molecular Devices, and Mission Synthetic and Lentiviral microRNA (miRNA) Inhibitors by Sigma-Aldrich.

Published
2013
Full Text
View/download PDF

13. EFFIENT.

Subjects
*CHEMICAL inhibitors
Abstract

The article evaluates the P2Y࣪12 platelet inhibitor Effient from Daiichi-Sankyo Co. Ltd. and Eli Lilly & Co.

Published
2009

14. EFFIENT.

Subjects
*CHEMICAL inhibitors
Abstract

The article evaluates the Effient, a platelet inhibitor, from Daiichi-Sankyo and Lilly, Eli and Co.

Published
2009

15. SPECIALIZING IN SUPERB THYROID SUPPORT.

Subjects
*HORMONE antagonists, *CHEMICAL inhibitors, *HEALTH, *THYROID antagonists, *WEBSITES
Abstract

The article evaluates effective solutions for hormone balancing in human body without side effects. The Green Willow Tree Company offers natural supplements for thyroid support, menopause, andropause, peri-menopause, bone health, enhancing libido, and more. Thyodine is their best product for thyroid health. It is the most potent non-prescription thyroid supplement available. Further information regarding Thyodine and many other hormone supplements can be availed from the company's web site www.greenwillowtree.com.

Published
2005

16. PRODUCT news.

Subjects
*OINTMENTS, *CHEMICAL inhibitors
Abstract

The article evaluates several pharmaceutical products, including the Ivy-Dry Defense lotion from Ivy-Dry Inc., the proton pump inhibitor Omeprazole from Perrigo Co. and the home test MyAllergyTest from ImmuneTech Inc.

Published
2008

18. HP Innovations.

Author

Blume, Adrienne

Subjects
*COMMERCIAL product evaluation, *CHEMICAL inhibitors, *CERAMICS, *EQUIPMENT & supplies
Abstract

The article evaluates several products including the TANSCIENT, a chemical inhibitor solution from Dorf Ketal Chemicals LLC, Model FC80 free chlorine analyzer from Electro-Chemical Devices (ECD) and the ceramic materials from Heat Transfer International (HTI).

Published
2015

19. Untitled.

Author

Jones, David

Subjects
*SUCCINATE dehydrogenase, *AGRICULTURAL chemicals, *CHEMICAL inhibitors
Abstract

The article offers information about various succinate dehydrogenase inhibitor (SDHI) products used in different on-farm and field-scale trials, wherein the SDHI products include the Aviator from crop science company Bayer CropScience, Adexar from chemical company BASF, and Seguris from chemical company Syngenta.

Published
2014

21. INHIBITOR.

Author

Moore, Kenneth J.

Subjects
*CHEMICAL inhibitors
Abstract

The article evaluates the ProteaseArrest protease inhibitor cocktail solution from G-Biosciences.

Published
2008

22. New polyolefin catalysts optimize operations.

Subjects
*CATALYSTS, *CHEMICAL inhibitors, *INDUSTRIAL equipment, *COMMERCIAL product evaluation
Abstract

The article evaluates two products from Grace Davidson including the Sylopol 53TH gas-phase catalyst and the Polytrak 8500 Series of PP catalysts.

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results